Jersey Shore Ready ...
Health Care: Health Services
GenMark Diagnostics Inc. (GNMK: NASDAQ)
$14.77 0.11 | 0.75%
05/24/13 - 04:00 PM ET
Portfolios with GNMK
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBarron's Insider Purchases ...
Latest GNMK Headlines from TheStreet
- 4 Stocks Under $5 Making Big Up Moves 07.10.12 | 02:07 pm
- GenMark Diagnostics Inc. Stock Upgraded (GNMK) 06.29.12 | 05:06 am
- GenMark Diagnostics Inc. Stock Downgraded (GNMK) 11.23.11 | 06:11 am
- GenMark Diagnostics Inc. Stock Upgraded (GNMK) 08.26.11 | 07:08 am
- GenMark Diagnostics Inc. Stock Downgraded (GNMK) 08.11.11 | 07:08 am
- GenMark Diagnostics Inc. Stock Upgraded (GNMK) 08.09.11 | 07:08 am
- GenMark Diagnostics To Present At The Piper Jaffray 22nd Annual Health Care Conference 11.24.10 | 09:11 am
- GenMark Diagnostics To Present At William Blair Emerging Growth Stock Conference 10.01.10 | 07:10 am
- GenMark IPO Better than Mirion IPO
05.25.10 | 06:05 am
Press Releases for GNMK
- GenMark Diagnostics Reports Fourth Quarter And Year End 2012 Results - Business Wire 03.12.13 | 04:03 pm
- GenMark Diagnostics Schedules Fourth Quarter And Full Year 2012 Financial Results And Conference Call For March 12, 2013 - Business Wire 02.28.13 | 05:02 pm
- GenMark Diagnostics To Present At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 01.04.13 | 04:01 pm
- GenMark Diagnostics To Present At The Canaccord Genuity Medical Technology & Diagnostics Forum - Business Wire 11.26.12 | 09:11 am
- GenMark Diagnostics To Present At The Piper Jaffray 24th Annual Healthcare Conference - Business Wire 11.20.12 | 06:11 pm
- GenMark Diagnostics Reports Third Quarter 2012 Results - Business Wire 11.07.12 | 06:11 pm
- GenMark Diagnostics Schedules Third Quarter 2012 Financial Results And Conference Call For November 8, 2012 - Business Wire 10.26.12 | 02:10 pm
- GenMark To Show Its All-Electronic, Sample-to-Answer Molecular Diagnostics Platform At The Association For Molecular Pathology Meeting - Business Wire 10.22.12 | 09:10 am
- GenMark Diagnostics Receives FDA Clearance For RVP Test - Business Wire 09.12.12 | 09:09 am
- GenMark Diagnostics To Present At Canaccord Genuity 32nd Annual Growth Conference - Business Wire 08.15.12 | 09:08 am
Partner Headlines for GNMK
- GenMark Diagnostics Earnings: Everything You Must Know Now - Wall St. Cheat Sheet 05.08.13 | 08:05 am
- FDA Clears GenMark's Newest Test - Analyst Blog - NASDAQ 09.13.12 | 04:09 pm
- Weekly CFO Buys Highlight: XPL, GNMK - GuruFocus 07.02.12 | 12:07 pm
- Weekly CEO Buys Highlight: SXL, JBSS, GNMK, CNDO, DCO - GuruFocus 06.30.12 | 02:06 pm
- GenMark Diagnostics Appoints Richard B. Slansky Chief Financial Officer - Benzinga 04.02.12 | 04:04 pm
- After Shaky August, IPO Market Attempts To Right Itself - Seeking Alpha 09.23.11 | 08:09 am
- 10 Rallying Small-Caps Bought Up By Insiders - Seeking Alpha 09.16.11 | 04:09 pm
- 2010 Year-End U.S. IPO Review and 2011 Outlook - Seeking Alpha 03.04.11 | 02:03 pm
- William Blair & Co. Initiates Outperform Rating on GenMark Diagnostics (GNMK) - Benzinga 07.12.10 | 09:07 am
